Feed Preview

Fast Growing

Microbiome and MS

Microbiome and MS diagram by

Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system which is characterized by inflammatory demyelination and neurodegeneration. Here is the latest research on the influence of the human microbiome on this dymyelinating disorder.

Top 20 most recent papers
Scientific Reports

Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course

Scientific ReportsNovember 11, 2019
R E VenturaM J Blaser
12
3
4
Cell Host & Microbe

Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-like Symptoms in Mice by Expanding Akkermansia muciniphila

Cell Host & MicrobeDecember 1, 2019
Shirong LiuHoward L Weiner
63
6
4
Multiple Sclerosis and Related Disorders

The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic review

Multiple Sclerosis and Related DisordersNovember 11, 2019
Wolfgang MarxRELIEF Trial team
17
5
Frontiers in Microbiology

Core Gut Bacteria Analysis of Healthy Mice

Frontiers in MicrobiologyMay 21, 2019
Jingjing WangXingpeng Wang
6
26
Lancet Neurology

The gut microbiome in neurological disorders

Lancet NeurologyNovember 23, 2019
John F CryanTimothy G Dinan
377
2
8
Autoimmunity Reviews

The gut microbiota perspective for interventions in MS

Autoimmunity ReviewsJune 10, 2019
Magdalena Zoledziewska
12
22
Neurology. Neuroimmunology and Neuroinflammation

Normal gut microbiome in NMDA receptor encephalitis

Neurology. Neuroimmunology and NeuroinflammationOctober 19, 2019
Julia HerkenHarald Prüss
24
2
8
International Journal of Molecular Sciences

Implications of Diet and The Gut Microbiome in Neuroinflammatory and Neurodegenerative Diseases

International Journal of Molecular SciencesJune 28, 2019
Sarah HirschbergAiden Haghikia
5
1
3
50
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Norepinephrine and intestinal microbiome in the early stages of demyelination: clinical-immunological parallels

Zhurnal nevrologii i psikhiatrii imeni S.S. KorsakovaJanuary 15, 2020
A A SviridovaA N Boyko
2
Clinical and Experimental Gastroenterology

Inflammation in gastrointestinal disorders: prevalent socioeconomic factors

Clinical and Experimental GastroenterologyAugust 15, 2019
Davide Giuseppe RibaldoneGiovanni Clemente Actis
15
13
Autoimmunity Reviews

Multiple sclerosis, the microbiome, TLR2, and the hygiene hypothesis

Autoimmunity ReviewsNovember 18, 2019
Nicholas J WaskoRobert B Clark
10
2
Multiple Sclerosis and Related Disorders

Bifidobacteria: A probable missing puzzle piece in the pathogenesis of multiple sclerosis

Multiple Sclerosis and Related DisordersSeptember 6, 2019
Mehdi ToghiSoudeh Ghafouri-Fard
18
8
bioRxiv

Predictive Metagenomic Analysis of Autoimmune Disease Identifies Robust Autoimmunity and Disease Specific Signatures

bioRxivSeptember 24, 2019
Angelina Volkova, Kelly V Ruggles
11
1
Multiple Sclerosis and Related Disorders

Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis

Multiple Sclerosis and Related DisordersJune 4, 2019
Gloria Dalla CostaVittorio Martinelli
16
8
Brain, Behavior, and Immunity

Monocyte mobilisation, microbiota & mental illness

Brain, Behavior, and ImmunityJuly 23, 2019
Marcel van de WouwJohn F Cryan
92
1
25
Cell Reports

Disrupting Myelin-Specific Th17 Cell Gut Homing Confers Protection in an Adoptive Transfer Experimental Autoimmune Encephalomyelitis

Cell ReportsOctober 10, 2019
Donovan DucCaroline Pot
31
1
29
Neurochemistry International

Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis

Neurochemistry InternationalMay 21, 2019
Qin ZengYongjun Lu
8
19
International Journal of Molecular Sciences

Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells

International Journal of Molecular SciencesNovember 7, 2019
George AndersonRussel J Reiter
4
7
Frontiers in Psychiatry

Autoimmune Diseases and Psychotic Disorders

Frontiers in PsychiatryApril 6, 2019
Rose Jeppesen, Michael Eriksen Benros
54
5
58
Current Opinion in Rheumatology

Microbiome and autoimmune diseases: cause and effect relationship

Current Opinion in RheumatologyJune 14, 2019
Ana Rita Nogueira, Yehuda Shoenfeld
3
13

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/microbiome-and-ms/300264ee-2362-4185-98b9-a2ca266c176a